[Interleukin-1 in pathogenesis of rheumatoid arthritis].
Iwakura
Yoichiro
Y
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000209:etiology*; D015551:Autoimmunity / Q000235:genetics; D023201:CD40 Ligand; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000502:physiology; D008562:Membrane Glycoproteins; D053278:OX40 Ligand; D017472:Receptors, Interleukin-1 / Q000502:physiology; D012795:Sialoglycoproteins / Q000502:physiology; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology
C507763:IL1RN protein, human; D018836:Inflammation Mediators; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D008562:Membrane Glycoproteins; D053278:OX40 Ligand; D017472:Receptors, Interleukin-1; D012795:Sialoglycoproteins; C089251:TNFSF4 protein, human; D023201:CD40 Ligand